DiagNodus Ltd. Industries
-
Manufacturing, Other
-
-
Medical / Health Care
-
-
The colorectal sampling system developed by DiagNodus allows non-invasively collecting highly informative samples suitable for detecting a number of other important diseases. In particular, collected colorectal mucus is a habitat of commensal microorganisms that are extremely important for normal functioning of the human gut. Therefore the use of this material in combination with modern microbiomic techniques can lead to the development of new diagnostic modalities for a range of common gastrointestinal...
Inflammatory bowel disease (IBD), largely comprising the two conditions, Crohn’s Disease and Ulcerative Colitis, is now emerging as a global health problem. It now affects about 6 million people in Europe and US, comprising up to 620,000 in the UK (IBD Standards UK, 2013 Update). The symptoms of diarrhoea, abdominal pain and bloody stool substantially affect the quality of life of sufferers, and complications...
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood...